Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Yearly Results - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 16:00
576.30
-30.75 (-5.07%)
VOLUME 349,893
LIVE
NSE
Oct 23, 15:59
575.85
-31.05 (-5.12%)
VOLUME 4,538,253
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Consolidated Yearly Results of Sun Pharmaceutical Industries

------------------- in Rs. Cr. -------------------
Mar '18 Mar '17 Mar '16 Mar '15 Mar '14
Net Sales/Income from operations 26,065.94 30,264.23 27,888.07 27,286.50 16,004.39
Other Operating Income 423.52 1,314.21 598.96 146.94 75.97
Total Income From Operations 26,489.46 31,578.44 28,487.03 27,433.44 16,080.36
EXPENDITURE
Consumption of Raw Materials 4,462.60 5,124.61 4,181.63 4,158.69 2,243.39
Purchase of Traded Goods 2,731.38 3,277.76 2,542.52 2,465.99 612.47
Increase/Decrease in Stocks 230.70 -271.63 -393.77 114.49 -76.54
Power & Fuel -- -- -- -- --
Employees Cost 5,367.05 4,902.30 4,772.31 4,429.86 2,074.44
Depreciation 1,499.84 1,264.75 1,037.53 1,294.83 409.37
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 8,089.60 8,456.13 9,226.02 8,200.77 4,031.02
P/L Before Other Inc., Int., Excpt. Items & Tax 4,108.29 8,824.52 7,120.79 6,768.81 6,786.21
Other Income 838.76 623.15 658.25 452.05 508.09
P/L Before Int., Excpt. Items & Tax 4,947.05 9,447.67 7,779.04 7,220.86 7,294.30
Interest 517.57 399.80 523.24 578.99 44.19
P/L Before Exceptional Items & Tax 4,429.48 9,047.87 7,255.80 6,641.87 7,250.11
Exceptional Items -950.50 -- -685.17 -237.75 -2,517.41
P/L Before Tax 3,478.98 9,047.87 6,570.63 6,404.12 4,732.70
Tax 845.19 1,211.57 913.77 914.69 790.76
P/L After Tax from Ordinary Activities 2,633.79 7,836.30 5,656.86 5,489.43 3,941.94
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 2,633.79 7,836.30 5,656.86 5,489.43 3,941.94
Minority Interest -446.80 -- -- -936.27 -737.53
Share Of P/L Of Associates -25.44 9.93 1.45 -12.56 --
Net P/L After M.I & Associates 2,161.55 7,846.23 5,658.31 4,540.60 3,204.41
Equity Share Capital 239.93 239.93 240.66 207.12 207.12
Reserves Excluding Revaluation Reserves 37,860.63 36,399.74 32,741.82 25,378.61 18,317.83
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 9.00 29.00 18.90 18.87 27.60
Diluted EPS 9.00 29.00 18.90 18.88 27.60
EPS After Extra Ordinary
Basic EPS 9.00 29.00 18.90 18.87 15.50
Diluted EPS 9.00 29.00 18.90 18.88 15.50
Public Share Holding
No Of Shares (Crores) -- -- -- 75.47 75.28
Share Holding (%) -- -- -- 36.44 36.35
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- 1.49 0.33
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- 1.13 0.25
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- 0.72 0.16
b) Non-encumbered
- Number of shares (Crores) -- -- -- 130.16 131.50
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- 98.87 99.75
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- 62.84 63.49
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for sunpharmaceuticalindustries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.